The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer’s disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.
Webinar: Dr. Catherine Diaz-Asper : Developing a New Dementia Screening Tool
December 2nd, 2021
Webinar : Dr . Catherine Diaz – Asper : Developing a New Dementia Screening Tool When : December 16th 2021 at 4pm EST . Zoom Link : Click here Meeting ID : 964 84…
New Developments in Alzheimer’s Disease Therapeutics
December 2nd, 2021
R . Scott Turner , PhD , MD Memory Disorders Program , MedStar Georgetown University Hospital Nov . 18 , 2021 Aducanumab ( Aduhelm ®) On June 7 , 2021 the FDA…
Alzheimer’s Association On Demand Webinars
June 29th, 2021
View some free , on demand webinars regarding a variety of Alzheimer ‘ s topics including Aducanmunab on the Alzheimer ‘ s Association website . View Here http…
Aducanumab (AduhelmTM) – the first disease-modifying treatment for Alzheimer’s disease approved by the US Food and Drug Administration, 7 June 2021
June 7th, 2021
Availability of Aduhelm remains unclear Coverage by Medicare and other third – party payers unknown More information to follow R . Scott Turner , PhD , MD…
Georgetown Lombardi Visiting Professor and Grand Rounds Lecture Series Featuring David Robbins, PhD Jan. 21
CENTILE Consultation for Health Education and Evaluation Research (CHEER) 2021-22 Session 2 Jan. 21
Bhussry Seminar Series – “The Force Awakens: Mechanoregulated Ion Transport in the Distal Nephron” Jan. 25
Building D, Suite 177
4000 Reservoir Road, N.W.,
Washington DC 20057
MGUH Department of Neurology
Pasquerilla Health Center (PHC), 7th Floor
3800 Reservoir Road, NW
Washington D.C. 20007
